Biochemical markers and the FDA Critical Path: How biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development
Karsdal, M.A., Henriksen, K., Leeming, D.J., Mitchell, P., Duffin, K., Barascuk, N., Klickstein, L., Aggarwal, P., Nemirovskiy, O., Byrjalsen, I., Qvist, P., Bay-Jensen, A.C., Dam, E.B., Madsen, S.H.,Volume:
14
Language:
english
Journal:
Biomarkers
DOI:
10.1080/13547500902777608
Date:
May, 2009
File:
PDF, 1.46 MB
english, 2009